USMLE Step 1 practice question: Warfarin-induced skin necrosis: early protein C depletion

USMLE Step 1Hematology/OncologyPharmacology

A 49-year-old woman comes to the emergency department because of painful skin lesions on her thighs and left breast that began yesterday. Five days ago, she was diagnosed with atrial fibrillation in the setting of moderate rheumatic mitral stenosis and was started on warfarin. She has not received heparin. Her sister had a deep venous thrombosis at age 31 years. Her temperature is 37.2°C (99°F), pulse is 88/min and irregularly irregular, and blood pressure is 128/76 mm Hg. Examination shows sharply demarcated, purple-to-black plaques with surrounding erythema and hemorrhagic bullae on both anterior thighs and the left breast. A low-pitched diastolic rumble is heard at the apex. Laboratory studies show a platelet count of 236,000/mm³ and an INR of 2.3. A skin biopsy specimen shows fibrin thrombi occluding dermal and subcutaneous venules with hemorrhagic necrosis and no inflammation of the vessel walls.

Which of the following best explains the pathogenesis of this patient's skin lesions?

  1. IgG antibodies against complexes of heparin and platelet factor 4
  2. Immune complex deposition in dermal postcapillary venules
  3. Calcification of cutaneous arterioles with intimal proliferation
  4. Excessive depletion of factors II, IX, and X causing dermal hemorrhage
  5. Faster decline of protein C activity than of procoagulant factors
Show answer and explanation

Correct answer: E. Faster decline of protein C activity than of procoagulant factors

This patient has warfarin-induced skin necrosis, a rare complication that typically appears 3 to 5 days after warfarin is started, often with a large loading dose and without concurrent heparin. Lesions favor areas with abundant subcutaneous fat (breasts, thighs, buttocks, abdomen) and progress from painful erythema to hemorrhagic bullae and full-thickness necrosis. Biopsy shows microvascular thrombosis without vasculitis. Her sister's early DVT suggests an inherited thrombophilia; heterozygous protein C deficiency is the classic predisposing factor (protein S deficiency also predisposes).

Warfarin inhibits vitamin K epoxide reductase (VKORC1), preventing regeneration of reduced vitamin K, which is required for γ-carboxylation of glutamate residues on factors II, VII, IX, and X and on the anticoagulant proteins C and S. Because warfarin blocks synthesis rather than removing existing factors, each protein falls according to its plasma half-life. Protein C (half-life ~8 hours) and factor VII (~6 hours) decline first, whereas factors IX (~24 hours), X (~40 hours), and II (prothrombin, ~60–72 hours) persist for days. The INR rises early because the PT is sensitive to factor VII, but the patient is transiently hypercoagulable: the natural anticoagulant (activated protein C, which inactivates factors Va and VIIIa) is depleted while thrombin generation is still largely intact. In a patient with a low baseline protein C level, this imbalance causes thrombosis of dermal venules and necrosis. This is also why patients with acute thrombosis must receive overlapping parenteral anticoagulation (eg, heparin) for at least 5 days and until the INR has been therapeutic for 24 hours.

Management: stop warfarin, give vitamin K, start a parenteral anticoagulant (heparin), and consider protein C concentrate or fresh frozen plasma; warfarin can later be reintroduced at a low dose under heparin coverage.

High-yield summary: Warfarin necrosis = days 3–5, fatty areas, protein C deficiency, transient hypercoagulable state because protein C (short half-life) falls before factors II, IX, and X. Prevent with heparin bridging and avoidance of loading doses.

Why the other options are wrong

  • A. IgG antibodies against complexes of heparin and platelet factor 4 — Heparin-induced thrombocytopenia is caused by IgG antibodies against heparin–PF4 complexes and can cause skin necrosis at injection sites and venous limb gangrene, but it requires heparin exposure and causes a falling platelet count; this patient received no heparin and has a normal platelet count.
  • B. Immune complex deposition in dermal postcapillary venules — Immune complex deposition in postcapillary venules causes leukocytoclastic (small-vessel) vasculitis, which presents as palpable purpura with neutrophilic inflammation and fibrinoid necrosis of vessel walls; the biopsy shows bland thrombi without vasculitis.
  • C. Calcification of cutaneous arterioles with intimal proliferation — Calcification of small cutaneous arterioles with intimal proliferation and thrombosis is characteristic of calciphylaxis (calcific uremic arteriolopathy), which occurs mainly in patients with end-stage kidney disease; warfarin is a risk factor, but the time course and biopsy findings here are not consistent.
  • D. Excessive depletion of factors II, IX, and X causing dermal hemorrhage — Depletion of factors II, IX, and X takes several days and produces bleeding (eg, ecchymoses, hematomas), not thrombotic necrosis; at day 5, these procoagulant factors are only partially reduced.

Key point

Warfarin-induced skin necrosis results from a transient hypercoagulable state caused by the rapid fall of protein C (short half-life) before the procoagulant factors II, IX, and X are depleted.

Memory hook

Warfarin's first victim is its ally: protein C drops first (short half-life) → clots before anticoagulation → skin necrosis. Bridge with heparin.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Cisplatin toxicity (ototoxicity, nephrotoxicity, hypomagnesemia): DNA cross-linkingUSMLE Step 1 · Hematology/OncologyTumor lysis syndrome: rasburicase mechanism and G6PD deficiencyUSMLE Step 1 · Hematology/OncologyHigh-risk febrile neutropenia after AML induction: empiric IV cefepime within 1 hourUSMLE Step 2 CK · Hematology/Oncology

All free questions →